The Effect of Hospital Fit 2.0 on Patients Physical Activity

Pulmonary Disease Clinical Trial

Official title:

The Effect of a Smartphone App With Accelerometer on Patients' Physical Activity: a Randomised Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04797130
• Other study ID #: NL75126.068.20
• Status: Completed
• Phase: N/A
• Start date: March 23, 2021
• Est. completion date: January 27, 2022

Study information

• Verified date: September 2022
• Source: Maastricht University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary objective of this study is to investigate if using Hospital Fit 2.0 as part of the usual care physiotherapy treatment of patients hospitalised at the department of Internal Medicine and the department of Pulmonology in MUMC+ will result in an increase in the amount of PA performed compared to patients who do not use Hospital Fit 2.0 as part of the physiotherapy treatment.

Description:

Rationale: Low physical activity (PA) levels are common in hospitalised patients. Digital health tools could be valuable to prevent negative effects of inactivity. We therefore developed Hospital Fit 1.0; a smartphone application with accelerometer, designed for hospitalised patients. It enables objective activity monitoring, provides patients insight in their recovery progress and offers a tailored exercise program. Hospital Fit 1.0 has recently been updated, resulting in the improved Hospital Fit 2.0. Improvements in the accelerometer algorithm are made, a goalsetting and reminder function are added, and data from the app can be linked to the electronic medical record. It is hypothesized that using Hospital Fit 2.0 as part of the physiotherapy treatment of hospitalised patients will result in an increase in the amount of PA performed compared to patients who do not use Hospital Fit 2.0 as part of the physiotherapy treatment. Objective: To investigate if using Hospital Fit 2.0 as part of the usual care physiotherapy treatment will result in an increase in the amount of PA performed compared to patients who did not use Hospital Fit 2.0 as part of the usual care physiotherapy treatment. Study design: Assessor blinded randomised controlled trial. Study population: 78 patients hospitalised equally distributed over the department of Internal Medicine and the department of Pulmonology at the Maastricht University Medical Center. Intervention (if applicable): PA will be measured with an accelerometer until discharge with a maximum of seven days in all patients. The control group receives usual care physiotherapy (n=39), while the intervention group uses Hospital Fit additionally (n=39). Main study parameters/endpoints: Primary outcome parameter: time spent walking per day (min). Secondary outcome parameters: time spent standing per day (min.), average time spent standing and walking (min.) measured over total measurement time (max. 7 days), number of transitions per day and average number of transitions measured over total measurement time (max. 7 days), number of times walking longer than 5 minutes per day and the average number measured over total measurement time (max.7 days), number of times sitting/lying longer than 30 minutes per day and the average number measured over total measurement time (max. 7 days) and the mILAS score per day (max. 7 days). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden and risks on patients are minimal. The control group will receive usual care physiotherapy and will wear an accelerometer. The intervention group will use Hospital Fit 2.0 additionally. Wearing a small accelerometer and using Hospital Fit 2.0 should not be a burden to patients. The only burden is the time it take to prepare subjects (install app, explain study). No invasive interventions will take place.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: January 27, 2022
• Est. primary completion date: January 27, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Aged between 18 and 75 years
• Receiving physiotherapy while hospitalised at the department of Internal Medicine department or the department of Pulmonology at the Maastricht University Medical Centre (MUMC+)
• Sufficient understanding of the Dutch language
• Having access to a smartphone
• Able to walk independently 2 weeks before admission, as scored on the Functional Ambulation Categories (FAC >3)

Exclusion Criteria:

• A contraindication to walking (as reported by the attending medical specialists in the medical record)
• A contraindication to wearing an accelerometer, fixed by a hypoallergenic plaster at the upper leg (such as active bilateral upper leg infection, severe edema or bilateral transfemoral amputation)
• Admission at the intensive care department
• Impaired cognition (delirium / dementia) as reported by the attending doctor
• Incapacitated subjects as reported by the attending medical specialist in the medical record. When any doubt arises, the patient will not be considered eligible
• A life expectancy shorter than 3 months as mentioned by the attending medical specialist in the medical record
• Previous participation in this study

Related Conditions & MeSH terms

• Internal Medicine
• Lung Diseases
• Pulmonary Disease
• Telemedicine

Intervention

Device:
• Hospital Fit 2.0
HF consists of a smartphone app combined to an accelerometer. HF provides patients and physiotherapists direct feedback on patients' physical activity behavior.. Individual goals regarding the number of minutes per day spent walking can be set by the therapist. HF also shows patients insight into their own recovery progress. During every treatment, the physiotherapist will evaluate the extent of functional recovery. In addition, Hospital Fit will give physiotherapists the option of creating a patient-specific exercise program supported by videos. During every treatment session, the patient and physiotherapist will evaluate (and if necessary adapt) the amount of activity performed since the previous treatment, the extent of functional recovery and the exercise program.

Locations

Country	Name	City	State
Netherlands	MaastrichtUMC	Maastricht	Limburg

Sponsors (1)

Lead Sponsor	Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time spent walking per day (min.)	Defined as the total number of minutes walking per day.	Period between inclusion and discharge, with a maximum of seven days
Secondary	Average time spent walking	Defined as the total number of minutes walking divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of seven days	Period between inclusion and discharge, with a maximum of seven days
Secondary	Time spent standing per day (min.)	Defined as the total number of minutes walking per day.	Period between inclusion and discharge, with a maximum of seven days
Secondary	Average time spent standing	Defined as the total number of minutes standing divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of seven days	Period between inclusion and discharge, with a maximum of seven days
Secondary	Number of transitions from a sedentary position (lying or sitting) to an active position (standing or walking) per day	Defined as the total number of transitions from being sedentary (lying or sitting) to being physically active (standing or walking) per day	Period between inclusion and discharge, with a maximum of seven days
Secondary	Average number of transitions from a sedentary position (lying or sitting) to an active position (standing or walking)	defined as the total number of transitions divided by the total number of valid measurement days in the period between inclusion and discharge with a maximum of seven days	Period between inclusion and discharge, with a maximum of seven days
Secondary	Number of times walking longer than five minutes	Defined as the total number of times per day a patient spent walking for more than 5 minutes continuously without being interrupted by a standing or sedentary activity	Period between inclusion and discharge, with a maximum of seven days
Secondary	Average number of times walking longer than 5 minutes	Defined as the total number of times per day a patient spent walking for more than 5 minutes continuously without being interrupted by a standing or sedentary activity, divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of seven days	Period between inclusion and discharge, with a maximum of seven days
Secondary	Number of times sitting/lying longer than 30 minutes	Defined as the total numer of times per day a patient spent more than 30 minutes lying and/or sitting without interrupting this behavior with a standing or walking activity.	Period between inclusion and discharge, with a maximum of seven days
Secondary	Average number of times sitting/lying longer than 30 minutes	Defined as the total numer of times per day a patient spent more than 30 minutes lying and/or sitting without interrupting this behavior with a standing or walking activity, divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of seven days	Period between inclusion and discharge, with a maximum of seven days
Secondary	mILAS score per day	Defined as the modified Iowa Level of Assistance Score per day	Period between inclusion and discharge, with a maximum of seven days